Just saw this on the website
Uropathogenic Escherichia Coli (UPEC): Pre Clinical work has begun at Monash University using a novel Hyper immune anti UPEC product produced by Immuron to treat one of the most common diseases, Urinary Tract Infections.
T2 diabetes - likely perfect target, page-28
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.002(2.15%) |
Mkt cap ! $21.65M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 10.0¢ | 9.5¢ | $16.76K | 170.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50946 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 160371 | 2 |
View Market Depth
| Last trade - 15.34pm 06/09/2024 (20 minute delay) ? |
| IMC (ASX) Chart |